Skip to main content

Table 3 Hazard risk of TP53 mutations on familial and sporadic ovarian cancer cases.

From: TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

 

# cases

HR

CI (95%)

p-value

Familial Cases

30

   

TP53 no mutation

14

1 (ref)

  

TP53 mutation

16

1.64

0.71 – 3.78

0.25

Sporadic cases

100

   

TP53 no mutation

26

1 (ref)

  

TP53 mutation

76

0.96

0.55 – 1.66

0.88

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us